173. Deputy Clare Daly asked the Minister for Health if the urgent introduction of a no-fault vaccine payment scheme for persons debilitated by narcolepsy as a result of being vaccinated with the drug Pandemrix will be considered; and if he will make a statement on the matter. (Question 20525/18 asked on 10 May 2018 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): The Programme for a Partnership Government includes a commitment to “… put in place a scheme, on a no-fault basis, that will respond to the needs of people with disability arising from vaccination.” The policy objectives in putting in place a scheme to meet the needs of people with disability arising from vaccination are to provide fair and just compensation for those who may have been injured by a vaccine, to reduce the costs to the State by providing ...

946. Deputy Clare Daly asked the Minister for Health the training programmes provided by his Department to general practitioners in detecting adverse reactions to the HPV vaccine; the directive under which general practitioners have to report or not report their findings in view of the initial figures for 2011 and 2012, as already published; and if he will make a statement on the matter. (Question 16285/18 asked on 17 Apr 2018 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): As this PQ refers to the training of general practitioners in relation to HPV and material provided by the HSE, I have referred it to the Health Service Executive for attention and direct reply to the Deputy. 
 ...

947. Deputy Clare Daly asked the Minister for Health the number of adverse reactions to the HPV vaccine reported by general practitioners to the HPRA in each of the years 2011 to 2017; and if he will make a statement on the matter. (Question 16286/18 asked on 17 Apr 2018 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): The information that the Deputy seeks in relation to the number of adverse reactions from the HPV vaccine is not readily available. Therefore, I have asked the Health Products Regulatory Authority (HPRA) to investigate the matter and reply directly to the Deputy.
The HPRA is responsible for monitoring the safety and quality of all medicines including vaccines that are licensed in Ireland and operates a national adverse reaction reporting system, which m...

392. Deputy Clare Daly asked the Minister for Health the assessments conducted by his Department in relation to the reasons girls did not complete the two-dose HPV vaccination course in 2016 and 2017; and his plans to adopt an approach of listening to testimony of girls in cases in which problems have occurred (details supplied); and if he will make a statement on the matter. (Question 11687/18 asked on 08 Mar 2018 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): Cervical cancer is the fourth most common cancer in women worldwide. Each year in Ireland around 300 women are diagnosed with cervical cancer and 90 die from the disease. All cervical cancers are linked to high risk Human Papillomavirus (HPV) types. In 2009 the National Immunisation Advisory Committee (NIAC) recommended HPV vaccination for all 12 year old girls to reduce their risk of cervical cancer and in September 2010 the HPV vaccination programm...

443. Deputy Clare Daly asked the Minister for Health the reason recommendations of the Oireachtas Joint Committee on Health and Children’s report on childhood immunisation of July 2001 that legislation be drawn up to provide for a no fault national vaccine injury compensation scheme has not been implemented (Question 24143/17 asked on 23 May 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 443 and 445 together.
I refer the Deputy to my reply to question number 379 on 16 May 2017. As I stated in my reply, my Department is considering how to implement the Programme for a Partnership Government commitment, which encompasses consideration of the implementation of the recommendations of the Vaccine Damage Steering Group. This includes the nature of any such scheme, whether it would be on a statutory or non-st...

444. Deputy Clare Daly asked the Minister for Health if he will establish an expert medical group on the HPV vaccination along the lines of the previous group established in November 1977 on the whooping cough vaccination. (Question 24144/17 asked on 23 May 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 444, 452 to 455, inclusive, 537 and 538 together.
Immunisation is regarded as one of the safest and most cost-effective of health care interventions and the importance of vaccination is acknowledged by all the major international health organisations. The World Health Organisation estimates that up to 3 million lives are saved each year as a result of vaccination and the scientific evidence is clear that benefits of vac...

445. Deputy Clare Daly asked the Minister for Health the reason an ex gratia payment scheme has not been established, in view of the recommendations of the vaccine damage steering group of June 2009 regarding the need to deal with issues for retrospective cases, in instances in which persons have been awaiting a resolution of these issues for decades; and if he will make a statement on the matter. (Question 24145/17 asked on 23 May 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 443 and 445 together.
I refer the Deputy to my reply to question number 379 on 16 May 2017. As I stated in my reply, my Department is considering how to implement the Programme for a Partnership Government commitment, which encompasses consideration of the implementation of the recommendations of the Vaccine Damage Steering Group. This includes the nature of any such scheme, whether it would be on a statutory or non-st...

21. Deputy Clare Daly asked the Minister for Health if he will provide the detail of the information held by his Department after November 2009 regarding the safety profile of the Pandemrix vaccine compared to other vaccines for swine flu; and if his Department was briefed by the Irish Medicines Board as to the heightened risk of serious adverse drug reactions associated with the drug. (Question 20206/17 asked on 03 May 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): As you are aware this matter is the subject of litigation in which plaintiffs allege personal injury in which they claim the development of narcolepsy (cataplexy) resulted from the administration of the H1N1 pandemic vaccine. An Order requiring the defendants to make Discovery was made in the High Court on 28 November 2016 in the most advanced case. Discovery is a legal process which must be carried out in accordance with Orders made by the Courts and...

868. Deputy Clare Daly asked the Minister for Health further to Parliamentary Questions Nos. 609 to 611 of 11 April 2017, the reason he has stated that there was more vaccine produced by a company (details supplied) purchased than that of another company; and the reason 90% of the swine flu vaccinations were of the pandemrix vaccine as distinct from cephlapan. (Question 19460/17 asked on 02 May 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 868 to 870, inclusive, and 872 and 873 together.
The Health Service Executive (HSE) was guided on all aspects of the pandemic influenza vaccination campaign by the Pandemic Expert Influenza Group and the National Immunisation Advisory Committee. I have been informed by the HSE that they had contracts in place for the provision of pandemic vaccine, with Baxter for 4.25 million doses of Celvapan vaccine, and with GSK for ...

869. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No.r 610 of 11 April 2017, the number of doses of pandemrix that were purchased; the number that were used; and the status of the unused vaccines. (Question 19461/17 asked on 02 May 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 868 to 870, inclusive, and 872 and 873 together.
The Health Service Executive (HSE) was guided on all aspects of the pandemic influenza vaccination campaign by the Pandemic Expert Influenza Group and the National Immunisation Advisory Committee. I have been informed by the HSE that they had contracts in place for the provision of pandemic vaccine, with Baxter for 4.25 million doses of Celvapan vaccine, and with GSK for ...

870. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No. 609 of 11 April 2017, the amount of money spent on the pandemrix vaccine. (Question 19462/17 asked on 02 May 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 868 to 870, inclusive, and 872 and 873 together.
The Health Service Executive (HSE) was guided on all aspects of the pandemic influenza vaccination campaign by the Pandemic Expert Influenza Group and the National Immunisation Advisory Committee. I have been informed by the HSE that they had contracts in place for the provision of pandemic vaccine, with Baxter for 4.25 million doses of Celvapan vaccine, and with GSK for ...

871. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No. 611 of 11 April 2017, the reason pandemrix continued to be used after 2009 when the Irish Medicines Board was in possession of facts that showed it had a far greater likelihood of adverse reactions. (Question 19463/17 asked on 02 May 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): The first reports of a link between pandemic influenza vaccination and narcolepsy came in the second half of 2010. In August 2010, the Swedish pharmacovigilance authority reported that it was investigating six cases of narcolepsy reported by health care professionals as a possible adverse event following the use of Pandemrix vaccine, used during the H1N1 2009 pandemic. This was followed later that month by reports from the Finnish National Institute fo...

872. Deputy Clare Daly asked the Minister for Health the cost of the swine flu vaccination programme; and the cost of the vaccines purchased, the public mass vaccination campaign, the setting up of emergency clinics around the country, the extra staff costs in hiring part time staff and for overtime, the media campaign and other associated costs. (Question 19464/17 asked on 02 May 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 868 to 870, inclusive, and 872 and 873 together.
The Health Service Executive (HSE) was guided on all aspects of the pandemic influenza vaccination campaign by the Pandemic Expert Influenza Group and the National Immunisation Advisory Committee. I have been informed by the HSE that they had contracts in place for the provision of pandemic vaccine, with Baxter for 4.25 million doses of Celvapan vaccine, and with GSK for ...

873. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No. 610 of 11 April 2017, if it is correct that the HSE had contracts in place for items (details supplied). (Question 19465/17 asked on 02 May 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 868 to 870, inclusive, and 872 and 873 together.
The Health Service Executive (HSE) was guided on all aspects of the pandemic influenza vaccination campaign by the Pandemic Expert Influenza Group and the National Immunisation Advisory Committee. I have been informed by the HSE that they had contracts in place for the provision of pandemic vaccine, with Baxter for 4.25 million doses of Celvapan vaccine, and with GSK for ...

1060. Deputy Clare Daly asked the Minister for Health his views on the fact that a group (details supplied) has lodged a complaint to the EU Ombudsman regarding the poor quality of EMA research regarding HPV vaccines. (Question 20384/17 asked on 02 May 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): Immunisation is regarded as one of the safest and most cost-effective of health care interventions and the importance of vaccination is acknowledged by all the major international health organisations. The World Health Organisation estimates that up to 3 million lives are saved each year as a result of vaccination and the scientific evidence is clear that benefits of vaccines outweigh the known side effects
The immunisation programme in Ireland is base...

609. Deputy Clare Daly asked the Minister for Health the amount of money spent on the pandemrix vaccine; and if he will make a statement on the matter. (Question 18167/17 asked on 11 Apr 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 609 to 611, inclusive, together.
A public health alert was received from the World Health Organisation (WHO) on 24 April 2009 indicating that human cases of influenza type A (H1N1) virus infection had been identified in the US and in Mexico. The Department of Health activated the National Plan for pandemic influenza. The plan was accompanied by guidance that had been developed by the Pandemic Influenza Expert Group (PI...

610. Deputy Clare Daly asked the Minister for Health the number of doses of pandemrix which were purchased; the number of doses which were used during the swine flu vaccination programme; the position regarding the remainder of those unused vaccines; and if he will make a statement on the matter. (Question 18168/17 asked on 11 Apr 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 609 to 611, inclusive, together.
A public health alert was received from the World Health Organisation (WHO) on 24 April 2009 indicating that human cases of influenza type A (H1N1) virus infection had been identified in the US and in Mexico. The Department of Health activated the National Plan for pandemic influenza. The plan was accompanied by guidance that had been developed by the Pandemic Influenza Expert Group (PI...

611. Deputy Clare Daly asked the Minister for Health his views on the decision to purchase the pandemrix vaccine and to facilitate its use post-November 2009, when the Irish Medicines Board was in possession of information which showed that it had a far greater likelihood of serious adverse impacts; and if he will make a statement on the matter. (Question 18169/17 asked on 11 Apr 2017 - Vaccination Programme Data)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 609 to 611, inclusive, together.
A public health alert was received from the World Health Organisation (WHO) on 24 April 2009 indicating that human cases of influenza type A (H1N1) virus infection had been identified in the US and in Mexico. The Department of Health activated the National Plan for pandemic influenza. The plan was accompanied by guidance that had been developed by the Pandemic Influenza Expert Group (PI...

152. Deputy Clare Daly asked the Minister for Health if his attention has been drawn to the content of an anti-vaccine propaganda film (details supplied); and the steps his Department will take to counter any inaccurate information regarding vaccinations that feature in this film. (Question 14689/17 asked on 23 Mar 2017 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): Immunisation is regarded as one of the safest and most cost-effective of health care interventions. The importance of immunisation is acknowledged by all the major international health organisations, particularly the World Health Organisation (WHO). The immunisation programmes in Ireland are based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of exper...

487. Deputy Clare Daly asked the Minister for Health if he will consider that parents and guardians should be given the option of providing consent for each HPV vaccination and not as it is at present, that is, consenting for at the start of the series of jabs; if he will consider providing the parents the right to give consent individually for the two vaccinations; and his views on the fact that this would allow the parents to monitor the health of their daughters after each vaccination. (Question 34594/16 asked on 15 Nov 2016 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): As this is a service matter, I have arranged for the question to be referred to the Health Service Executive for direct reply to the Deputy.
 ...

488. Deputy Clare Daly asked the Minister for Health if there is a possibility of aluminium in Gardasil forms of HPV vaccines crossing the blood brain barrier; if he will publish any data held by his Department on this subject; and if he will make a statement on the matter. (Question 34595/16 asked on 15 Nov 2016 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 488 to 491, inclusive, together.
The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of experts in a number of specialties including infectious diseases, paediatrics and public health. The committee’s recommendations are informed by public health advice and international best prac...

489. Deputy Clare Daly asked the Minister for Health if there is a possibility of potential synergistic toxicity of aluminium in HPV vaccines. (Question 34596/16 asked on 15 Nov 2016 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 488 to 491, inclusive, together.
The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of experts in a number of specialties including infectious diseases, paediatrics and public health. The committee’s recommendations are informed by public health advice and international best prac...

490. Deputy Clare Daly asked the Minister for Health if pandemrix was at one time considered as safe as the HPV vaccines and that the benefits outweighed the risks; and if there is a possibility that the many autoimmune reactions being experienced by HPV vaccinated girls are following a similar pattern of neurological disturbances. (Question 34597/16 asked on 15 Nov 2016 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 488 to 491, inclusive, together.
The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of experts in a number of specialties including infectious diseases, paediatrics and public health. The committee’s recommendations are informed by public health advice and international best prac...

491. Deputy Clare Daly asked the Minister for Health the data that the manufacturer submitted to the EMA which indicated that those pre-exposed to vaccine relevant HPV may experience a 44.6% increased risk of pre-cancerous lesions after vaccination with Gardasil; and the steps in place to monitor cervical cancer rates in the HPV vaccinated population. (Question 34598/16 asked on 15 Nov 2016 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): I propose to take Questions Nos. 488 to 491, inclusive, together.
The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of experts in a number of specialties including infectious diseases, paediatrics and public health. The committee’s recommendations are informed by public health advice and international best prac...

453. Deputy Clare Daly asked the Minister for Health if the recent complaint by a centre (details supplied) regarding maladministration at the EMA in regard to a drug has been noted by his Department; and if he will make a statement on the matter. (Question 31879/16 asked on 25 Oct 2016 - Vaccination Programme)

Minister for Health (Deputy Simon Harris): The HPV vaccine, which was introduced in 2010, protects girls from cervical cancer when they are adults. It is available free of charge from the HSE for all girls in the first year of secondary school. Each year in Ireland around 300 women are diagnosed with cervical cancer and there are approximately 70 deaths per year. The HPV vaccine protects against two high risk types of HPV that cause 73% of all cervical cancers.
I am aware of claims of an asso...